This activity is intended for cardiologists, pediatricians, critical care clinicians, family medicine and primary care clinicians, nurses, pharmacists, physician assistants, and other members of the health care team who care for patients with congenital heart disease.
The goal of this activity is that learners will be better able to describe recent evidence regarding the transition to adult care for adolescents with congenital heart disease and considerations for the development of congenital heart disease transition programs, based on an updated scientific statement from the American Heart Association.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.
Medscape designates this continuing education activity for 0.25 contact hour(s) ( 0.025 CEUs) (Universal Activity Number: JA0007105-0000-22-106-H01-P).
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 4/22/2023. PAs should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 4/22/2022
Valid for credit through: 4/22/2023
processing....
Most people who are born with a congenital heart defect (CHD), including complex heart conditions, now survive into adulthood, and the smooth transition from pediatric to adult-centered care is key to their health, survival, and quality of life, the American Heart Association (AHA) says in a new scientific statement. Adolescents and young adults who are ready to transition from pediatric to adult care are estimated to make up 15% to 20% of the overall population with CHD in the US. Furthermore, an estimated 1.4 million or more adults with CHD live in the US, yet fewer than 30% are currently in subspecialty care. Clarifying potential barriers to successful health care transition is essential for uninterrupted health care from adolescence through adulthood.
"As physicians caring for adults with congenital heart disease, we see the consequences of patients who fall out of care and then return to care when they feel sick," Anitha S. John, MD, PhD, chair of the scientific statement writing group, says in a news release.
"At that point, they have been without medical care for a period of time, and when they return to the healthcare system, they may have developed complications that could have been avoided had they remained in care," adds Dr John, medical director of the Washington Adult Congenital Heart Program at Children's National Hospital, Washington, DC.
The statement was published online March 17 in the Journal of the American Heart Association.
The AHA first issued a scientific statement on best practices for managing the transition to adult-centered care for CHD in 2011.
Since then, efforts have been made to include transition programming as part of pediatric CHD programs, but there remain "significant challenges" to successful implementation, the writing group notes.
The updated statement summarizes the latest research regarding specific considerations in designing and creating successful transition programs for young people with CHD. It emphasizes the need for an interdisciplinary team approach to ensure a successful transition process.
The statement updates 3 sections relevant to a seamless transition of care:
The statement calls on healthcare professionals to gain a broader understanding of the transition needs and barriers to successful transition and help coordinate the integration into adult-centered care for both primary and specialty care.
The writing group acknowledges that "significant knowledge gaps" remain and calls for future research in several areas, including the ideal timing for transition and identifying barriers to successful transition, especially for underserved populations.
The consequences of poor healthcare transition are "great," and collecting information on outcomes through organized, multifaceted, collaborative approaches to transition is key to improving the lifelong care of individuals with CHD, they say.
"It is important to involve individuals and families in research. Collaboration during this transition is critical to improving the lifelong care of people with congenital heart disease," Dr John adds in the news release.
This scientific statement was prepared by the volunteer writing group on behalf of the AHA's Adults With Congenital Heart Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young and the Council on Clinical Cardiology; the Council on Cardiovascular and Stroke Nursing; the Council on Arteriosclerosis, Thrombosis, and Vascular Biology; and the Stroke Council.
J Am Heart Assoc. Published online March 17, 2022.[1]